In recent years, many authors in the world have proposed many new biomarkers in the aim of early and precise diagnosis of renal diseases, such as: Cystatin C, BTP, clusterin, CD 44, proteomics methods, etc... These new findings have been improved to be used effectively in clinical medicine.